Yarrow Bioscience (YARW) Tax Provisions (2019 - 2024)

Yarrow Bioscience's (YARW) quarterly Tax Provisions came in at $4000.0 in Q4 2024, down 69.23% on a QoQ basis from $13000.0 in Q4 2022.

Yarrow Bioscience (YARW) Tax Provisions (2019 - 2024) Analysis & Trends

Yarrow Bioscience (YARW) has 5 years of Tax Provisions data on file, last reported at $4000.0 in Q4 2024.

Quarterly Tax Provisions changed N/A year-over-year to $4000.0 in Q4 2024, while the trailing twelve-month figure through Mar 2026 was $4000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $4000.0, changed 0.0% from the prior year.
Tax Provisions fell to $4000.0 in Q4 2024, from $13000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $13000.0 in Q4 2022 to a low of -$448000.0 in Q4 2021.
A 4-year average of -$137800.0 and a median of $1000.0 in 2020 frame the typical range for Tax Provisions.
The widest YoY moves for Tax Provisions: up 102.9% in 2022, down 102.9% in 2022.
Tracing YARW's Tax Provisions over 4 years: stood at $1000.0 in 2020, then sank by 44900.0% to -$448000.0 in 2021, then jumped by 102.9% to $13000.0 in 2022, then tumbled by 69.23% to $4000.0 in 2024.
The last three Tax Provisions figures came in at $4000.0 (Q4 2024), $13000.0 (Q4 2022), and -$448000.0 (Q4 2021), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Yarrow Bioscience	31.25 Mn	8.33 Mn	-	-

Download Data